Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

References

• De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. 2013. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 24(8):698–706. doi:10.1016/j.ejim.2013.03.019
   PubMed Web of Science ®Google Scholar
• Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Jr DC G, Halkey WE, Krousel-Wood M, et al. 2017. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure. Results from SPRINT (Systolic Blood Pressure Intervention Trial) ambulatory blood pressure study. Hypertension. 69(1):42–50. doi:10.1161/HYPERTENSIONAHA.116.08076
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, Aronow WS. 2020. Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol. Feb. 3:2047487320903611. doi:10.1177/2047487320903611
   Google Scholar
• Heneghan C, O’Sullivan J, Mahtani KR. 2020 Jan 28. Should blood pressure medications be taken at bedtime? BMJ Evid Based Med. bmjebm-2019-111311. doi:10.1136/bmjebm-2019-111311
   Google Scholar
• Hermida RC. 2016. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the Hygia Project. Chronobiol Int. 33(7):906–936. doi:10.1080/07420528.2016.1181078
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2013a. Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol Int. 30(1–2):55–67. doi:10.3109/07420528.2012.701457
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 27(8):1629–1651. doi:10.3109/07420528.2010.510230
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011a. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 34(6):1270–1276. doi:10.2337/dc11-0297/-/DC1
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011b. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 22(12):2313–2321. doi:10.1681/ASN.2011040361
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2016a. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Diabetologia. 59(2):255–265. doi:10.1007/s00125-015-3749-7
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2018a. Risk of incident chronic kidney disease is better reduced by bedtime than upon awakening ingestion of hypertension medications. Hypertens Res. 41(5):342–353. doi:10.1038/s41440-018-0029-1
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2016b. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39(5):277–292. doi:10.1007/s00125-015-3748-8
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2019. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. Oct. 22(ehz754). doi:10.1093/eurheartj/ehz754.
   Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018b. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39(47):4159–4171. doi:10.1093/eurheartj/ehy475
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Mojón A. 2020a. Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial. Chronobiol Int. In press. doi:10.1080/07420528.2020.1771356
   Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, for the Hygia Project Investigators. 2020b. Comparing the design of the primary-care based Hygia Chronotherapy Trial and the internet-based TIME study. Eur Heart J. 41(16):1608. doi:10.1093/eurheartj/ehaa276
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013b. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30(3):355–410. doi:10.3109/07420528.2013.750490
   PubMed Web of Science ®Google Scholar
• Kim SYH, Miller FG. 2015. Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs. Clin Trials. 12(6):557–563. doi:10.1177/1740774515607213
   PubMed Web of Science ®Google Scholar
• Kittel M. 2019. NICE guidelines on hypertension in adults: take blood pressure tablets at night, measure blood pressure at home. BMJ. 367:I6570. doi:10.1136/bmj.I6570
   Google Scholar
• Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G. 2020. Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the Hygia project. Blood Pressure. 29(3):135–136. doi:10.1080/08037051.2020.1747696
   PubMed Web of Science ®Google Scholar
• Linden K, Mailey J, Kearney A, Menown IBA. 2020. Advances in cardiology 2019: A summary of key clinical trials. Adv Ther. 37(6):2620–2645. doi:10.1007/s12325-020-01355-5
   PubMed Web of Science ®Google Scholar
• Mathur P, Kadavath S, Marsh JD, Mehta JL 2019. Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs. Eur Heart J. Nov. 14(ehz836). doi:10.1093/eurheartj/ehz836
   Google Scholar
• Mojón A, Hermida RC, Fernández JR. 2013. System for clinical research and clinical management of cardiovascular risk using ambulatory blood pressure monitoring and actigraphy. U.S. Patent No. 8,428,965-B2. Washington DC: US Patent and Trademark.
   Google Scholar
• Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. 2015. Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 162(3):192–204. doi:10.7326/M14-1539
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014a. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32(12):2332–2340. doi:10.1097/HJH.0000000000000355
   PubMed Web of Science ®Google Scholar
• Roush GC, Fapohunda J, Kostis JB. 2014b. Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 16(8):561–568. doi:10.1111/jch.12354
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67(4):693–700. doi:10.1161/HYPERTENSIONAHA.115.06981
   PubMed Web of Science ®Google Scholar
• Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. 2015. Treatment of hypertension with chronotherapy: is it time? Ann Pharmacother. 49(3):323–334.
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. 2008. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 336(7653):1114–1117. doi:10.1136/bmj.39553.670231.25
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 39(33):3021–3104. doi:10.1093/eaurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Wingo MT, Bornstein SL, Szostek JH, Mauck KF, Post JA, Wieland ML. Update in Outpatient General Internal Medicine: practice-changing evidence published in 2019. Am J Med. 2020 Apr 2. S0002-9343(20)30227-8. doi:10.1016/j.amjmed.2020.03.033.
   PubMedGoogle Scholar
• Zhao P, Xu P, Wan C, Wang Z 2011. Evening versus morning dosing regimen drug therapy for hypertension. The Cochrane Database of Systematic Reviews. 10(CD004184). doi:10.1002/14651858.CD004184.pub2
   Google Scholar